Combined Screening for Early Detection of Pre-Eclampsia
AbstractAlthough the precise pathophysiology of pre-eclampsia remains unknown, this condition continues to be a major cause of maternal and fetal mortality. Early prediction of pre-eclampsia would allow for timely initiation of preventive therapy. A combination of biophysical and biochemical markers are superior to other tests for early prediction of the development of pre-eclampsia. Apart from the use of parameters in first-trimester aneuploidy screening, cell-free fetal DNA quantification is emerging as a promising marker for prediction of pre-eclampsia. This article reviews the current research of the most important strategies for prediction of pre-eclampsia, including the use of maternal risk factors, mean maternal arterial pressure, ultrasound parameters, and biomarkers. View Full-Text
Share & Cite This Article
Park, H.J.; Shim, S.S.; Cha, D.H. Combined Screening for Early Detection of Pre-Eclampsia. Int. J. Mol. Sci. 2015, 16, 17952-17974.
Park HJ, Shim SS, Cha DH. Combined Screening for Early Detection of Pre-Eclampsia. International Journal of Molecular Sciences. 2015; 16(8):17952-17974.Chicago/Turabian Style
Park, Hee J.; Shim, Sung S.; Cha, Dong H. 2015. "Combined Screening for Early Detection of Pre-Eclampsia." Int. J. Mol. Sci. 16, no. 8: 17952-17974.